Health care: the bill against the drug middlemen
What they say
Her campaign account says she wrote the law against the drug middlemen and that the House passed her bill to lower premiums.
“So I wrote the law to break the drug middlemen, and the House passed my bill to lower premiums for all Americans.”
What the record shows ·
H.R. 6703, the Lower Health Care Premiums for All Americans Act, is her own bill: she is its sponsor and introduced it on December 15, 2025. The House passed it 216 to 211 on December 17, 2025 (Roll Call 349), having rejected a motion to recommit 210 to 218 the same day, and the Senate received it on December 18. It is not law. Its second title, Lowering Health Care Premiums for Everyone, has two sections. Section 201 writes oversight of entities that provide pharmacy benefit management services into the Public Health Service Act, the Employee Retirement Income Security Act and the Internal Revenue Code: for plan years beginning thirty months after enactment such an entity would have to report to the group health plan it serves at least every six months, in plain language and in a machine-readable format, and no plan, issuer or such entity could contract with anyone who would limit or delay the information those reports require. The bill never uses the phrase pharmacy benefit manager; its own term is an entity providing pharmacy benefit management services, and the words pharmacy benefit appear 88 times in the text the House passed. Spread pricing appears nowhere in it, and it carries no divestiture or ownership provision. Section 202 permanently appropriates the cost-sharing reduction payments of section 1402 of the Affordable Care Act for plan years beginning January 1, 2027, and bars those funds from any qualified health plan that covers abortion, except where the pregnancy threatens the mother's life or results from rape or incest. The first title, Improving Health Care Options for Workers, is association health plans, an exclusion from the definition of health insurance coverage for certain medical stop-loss insurance, and health reimbursement arrangements.
Limit: The bill is hers, the House did pass it, and its second title is about pharmacy benefit managers, which is what the drug middlemen names. Two things the record does not carry. It is not law: it passed one chamber and has sat in the Senate since December 18, 2025. And what section 201 does to those entities is require them to disclose, twice a year, in a form the health plan can read; the text the House passed bans no practice and breaks up nothing, so that verb is the post's characterization of a reporting requirement. The post names the middlemen only, and section 202 is the part of the same title with the plainest effect on premiums and the sharpest politics: it funds the Affordable Care Act's cost-sharing reductions permanently and withholds that money from plans covering abortion. Whether the bill would lower premiums is a question about its effects, which this card does not assess.